Making Objective Drug Evidence Revisions for New Labeling Act of 2020 : report (to accompany H.R. 5668) (including cost estimate of the Congressional Budget Office)
(Visualizza in formato marc)
(Visualizza in BIBFRAME)
| Titolo: |
Making Objective Drug Evidence Revisions for New Labeling Act of 2020 : report (to accompany H.R. 5668) (including cost estimate of the Congressional Budget Office)
|
| Pubblicazione: | [Washington, D.C.] : , : [U.S. Government Publishing Office], , [2020] |
| Descrizione fisica: | 1 online resource (14 pages) |
| Soggetto topico: | Generic drugs - Law and legislation - United States |
| Generic drugs - Labeling - United States | |
| Generic drugs - Safety regulations - United States | |
| Warning labels - Government policy - United States | |
| Soggetto genere / forma: | Legislative materials. |
| Note generali: | "November 16, 2020." |
| Nota di bibliografia: | Includes bibliographical references. |
| Altri titoli varianti: | Making Objective Drug Evidence Revisions for New Labeling Act of 2020 |
| Titolo autorizzato: | Making Objective Drug Evidence Revisions for New Labeling Act of 2020 |
| Formato: | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione: | Inglese |
| Record Nr.: | 9910715015003321 |
| Lo trovi qui: | Univ. Federico II |
| Opac: | Controlla la disponibilità qui |